Axxcess Wealth Management LLC Purchases 3,793 Shares of Colgate-Palmolive (NYSE:CL)

Axxcess Wealth Management LLC lifted its stake in Colgate-Palmolive (NYSE:CL) by 7.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 54,588 shares of the company’s stock after buying an additional 3,793 shares during the period. Axxcess Wealth Management LLC’s holdings in Colgate-Palmolive were worth $4,351,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in the stock. OFI Invest Asset Management acquired a new stake in shares of Colgate-Palmolive during the third quarter valued at about $25,000. Avion Wealth lifted its stake in shares of Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after purchasing an additional 175 shares during the period. McGlone Suttner Wealth Management Inc. acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $34,000. Kayne Anderson Rudnick Investment Management LLC boosted its position in shares of Colgate-Palmolive by 142.0% during the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after purchasing an additional 291 shares in the last quarter. Finally, West Branch Capital LLC grew its stake in Colgate-Palmolive by 24.0% during the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after purchasing an additional 132 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Insider Activity

In related news, insider Jennifer Daniels sold 3,538 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total value of $299,562.46. Following the completion of the transaction, the insider now directly owns 59,698 shares in the company, valued at approximately $5,054,629.66. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, CEO Noel R. Wallace sold 29,772 shares of the stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $84.06, for a total transaction of $2,502,634.32. Following the transaction, the chief executive officer now owns 301,343 shares in the company, valued at $25,330,892.58. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Jennifer Daniels sold 3,538 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total transaction of $299,562.46. Following the sale, the insider now owns 59,698 shares of the company’s stock, valued at $5,054,629.66. The disclosure for this sale can be found here. Insiders sold a total of 159,048 shares of company stock worth $13,336,846 in the last quarter. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Trading Down 0.0 %

Shares of Colgate-Palmolive stock traded down $0.03 during trading on Friday, reaching $92.88. 5,432,695 shares of the stock were exchanged, compared to its average volume of 4,878,342. The company has a quick ratio of 0.28, a current ratio of 1.06 and a debt-to-equity ratio of 13.21. The firm has a market cap of $76.20 billion, a price-to-earnings ratio of 29.39, a price-to-earnings-growth ratio of 3.43 and a beta of 0.40. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $93.25. The stock’s fifty day moving average is $88.35 and its 200 day moving average is $82.21.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.04. The business had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The business’s revenue was up 6.2% on a year-over-year basis. During the same quarter last year, the business posted $0.73 EPS. As a group, equities research analysts expect that Colgate-Palmolive will post 3.52 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.15%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s payout ratio is presently 63.29%.

Analyst Ratings Changes

Several brokerages have recently commented on CL. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. Wells Fargo & Company lifted their price target on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a research note on Monday, April 29th. Citigroup increased their price objective on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, April 16th. Stifel Nicolaus boosted their target price on Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, April 29th. Finally, The Goldman Sachs Group began coverage on shares of Colgate-Palmolive in a research note on Friday, March 1st. They issued a “buy” rating and a $93.00 price objective on the stock. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $91.44.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.